Answer:
The promoter
Explanation:
The promoter region is the region of DNA sequence which the RNA polymer binds to to initiate transcription. In the archae and eukaryotes, the core portion of the promoter region is called the TATA BOX. The promoter region is also located upstream of the DNA and can about a 100-1000 base pairs long.
<span>not move since their is an equal concentration between the two sides.
Diffusion
occurs because of the movement of molecules from the region of higher
concentration to the region of lower concentration. This movement of
molecules occurs due to a thermal motion. Diffusion normally occurs
between two compartments having difference in concentration. In case of
fluid it moves from the region of higher concentration to the region of
concentration until a balance is reached. The process of diffusion is
very important for the humans as well. The oxygen that humans breathe in
gets diffused with the blood.<span>
</span></span>
Answer: The answer is .007 I believe. If I'm right please mark me brainiest
Explanation:
I just took the test and some teachers are taking .008 but some only take .007 so yea
Not they don't each cell is individual they don't connect
<u>Stem cell </u>research has the potential to significantly impact the development of disease-modifying treatments for Parkinson’s disease with considerable progress made in creating dopamine-progressing cells.
Explanation:
Parkinson’s disease, a neurodegenerative disease, leads to reduction of dopamine (a neurochemical messenger which carries messages involving thinking and body movements to brain) in the body because the disease will target and kill dopamine-producing nerve cells (neurons). This leads to loss of movement and thinking abilities which are activated by dopamine.
Stem cells research is done to study about the prospects of stem cells in stem cell therapy for Parkinson’s patients as a viable source of new dopamine nerve cells. Research has been involved in growing stem cells to replace or regenerate dopamine-producing nerve cells by using embryonic stem cells or induced pluripotent stem cells as a treatment modality in Parkinson’s disease.
